Literature DB >> 8613356

Oral immunization with an attenuated vaccine strain of Salmonella typhimurium expressing the serine-rich Entamoeba histolytica protein induces an antiamebic immune response and protects gerbils from amebic liver abscess.

T Zhang1, S L Stanley.   

Abstract

Attenuated salmonellae represent attractive candidates for the delivery of foreign antigens by oral vaccination. In this report, we describe the high-level expression of a recombinant fusion protein containing the serine-rich Entamoeba histolytica protein (SREHP), a protective antigen derived from virulent amebae, and a bacterially derived maltose-binding protein (MBP) in an attenuated strain of Salmonella typhimurium. Mice and gerbils immunized with S. typhimurium expressing SREHP-MBP produced mucosal immunoglobulin A antiamebic antibodies and serum immunoglobulin G antiamebic antibodies. Gerbils vaccinated with S typhimurium SREHP-MBP were protected against amebic liver abscess, the most common extraintestinal complication of amebiasis. Our findings indicate that the induction of mucosal and immune responses to the amebic SREHP antigen is dependent on the level of SREHP-MBP expression in S. typhimurium and establish that oral vaccination with SREHP can produce protective immunity to invasive amebiasis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8613356      PMCID: PMC173957          DOI: 10.1128/iai.64.5.1526-1531.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Serodiagnosis of invasive amebiasis using a recombinant Entamoeba histolytica antigen-based ELISA.

Authors:  K Myung; D Burch; T F Jackson; S L Stanley
Journal:  Arch Med Res       Date:  1992       Impact factor: 2.235

Review 2.  Delivery of antigens by recombinant avirulent Salmonella strains.

Authors:  T A Doggett; R Curtiss
Journal:  Adv Exp Med Biol       Date:  1992       Impact factor: 2.622

3.  Cloning and expression of a membrane antigen of Entamoeba histolytica possessing multiple tandem repeats.

Authors:  S L Stanley; A Becker; C Kunz-Jenkins; L Foster; E Li
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

4.  Hybrid hepatitis B virus core-pre-S proteins synthesized in avirulent Salmonella typhimurium and Salmonella typhi for oral vaccination.

Authors:  F Schödel; S M Kelly; D L Peterson; D R Milich; R Curtiss
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

5.  Oral immunization with the dodecapeptide repeat of the serine-rich Entamoeba histolytica protein (SREHP) fused to the cholera toxin B subunit induces a mucosal and systemic anti-SREHP antibody response.

Authors:  T Zhang; E Li; S L Stanley
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

6.  Serodiagnosis of invasive amebiasis using a recombinant Entamoeba histolytica protein.

Authors:  S L Stanley; T F Jackson; S L Reed; J Calderon; C Kunz-Jenkins; V Gathiram; E Li
Journal:  JAMA       Date:  1991-10-09       Impact factor: 56.272

7.  Protection of gerbils from amebic liver abscess by immunization with recombinant Entamoeba histolytica 29-kilodalton antigen.

Authors:  C J Soong; B E Torian; M D Abd-Alla; T F Jackson; V Gatharim; J I Ravdin
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

8.  Protection of gerbils from amebic liver abscess by immunization with a recombinant Entamoeba histolytica antigen.

Authors:  T Zhang; P R Cieslak; S L Stanley
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

9.  Antibodies to the serine rich Entamoeba histolytica protein (SREHP) prevent amoebic liver abscess in severe combined immunodeficient (SCID) mice.

Authors:  T Zhang; P R Cieslak; L Foster; C Kunz-Jenkins; S L Stanley
Journal:  Parasite Immunol       Date:  1994-05       Impact factor: 2.280

10.  Immunogenicity of the recombinant serine rich Entamoeba histolytica protein (SREHP) amebiasis vaccine in the African green monkey.

Authors:  S L Stanley; J L Blanchard; N Johnson; L Foster; C Kunz-Jenkins; T Zhang; K Tian; F B Cogswell
Journal:  Vaccine       Date:  1995-07       Impact factor: 3.641

View more
  16 in total

1.  The effect of immunization with porins on gut pathophysiological response in rats infected with Salmonella typhimurium.

Authors:  A Mittal; S Ghosh; C K Nain; N K Ganguly
Journal:  Mol Cell Biochem       Date:  1999-11       Impact factor: 3.396

Review 2.  Progress towards development of a vaccine for amebiasis.

Authors:  S L Stanley
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

Review 3.  The future for vaccine development against Entamoeba histolytica.

Authors:  Jeanie Quach; Joëlle St-Pierre; Kris Chadee
Journal:  Hum Vaccin Immunother       Date:  2014-02-06       Impact factor: 3.452

4.  The effect of type-1 fimbrial immunization on gut pathophysiological response in rats infected with Salmonella enterica subsp. enterica serovar Typhimurium.

Authors:  Amrisha Verma; Sulagna Basu; Sujata Ghosh; S Majumdar; N K Ganguly
Journal:  Mol Cell Biochem       Date:  2005-05       Impact factor: 3.396

5.  Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine-rich Entamoeba histolytica protein fused to the cholera toxin B subunit induces systemic and mucosal antiamebic and anti-V. cholerae antibody responses in mice.

Authors:  E T Ryan; J R Butterton; T Zhang; M A Baker; S L Stanley; S B Calderwood
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

6.  Mucosal immunogenicity of a holotoxin-like molecule containing the serine-rich Entamoeba histolytica protein (SREHP) fused to the A2 domain of cholera toxin.

Authors:  F Sultan; L L Jin; M G Jobling; R K Holmes; S L Stanley
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

7.  Oral vaccination with recombinant Yersinia enterocolitica expressing hybrid type III proteins protects gerbils from amebic liver abscess.

Authors:  Hannelore Lotter; Holger Rüssmann; Jürgen Heesemann; Egbert Tannich
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

Review 8.  Host-pathogen interaction in amebiasis and progress in vaccine development.

Authors:  C D Huston; W A Petri
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-09       Impact factor: 3.267

9.  The maltose-binding protein as a scaffold for monovalent display of peptides derived from phage libraries.

Authors:  M B Zwick; L L Bonnycastle; K A Noren; S Venturini; E Leong; C F Barbas; C J Noren; J K Scott
Journal:  Anal Biochem       Date:  1998-11-01       Impact factor: 3.365

10.  Experimental infection of Mongolian gerbils with wild-type and mutant Helicobacter pylori strains.

Authors:  H P Wirth; M H Beins; M Yang; K T Tham; M J Blaser
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.